CureVac (CVAC) Enterprise Value (2019 - 2025)
Historic Enterprise Value for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to -$566.8 million.
- CureVac's Enterprise Value fell 2697.08% to -$566.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$566.8 million, marking a year-over-year decrease of 2697.08%. This contributed to the annual value of -$518.7 million for FY2024, which is 1899.32% down from last year.
- As of Q3 2025, CureVac's Enterprise Value stood at -$566.8 million, which was down 2697.08% from -$448.0 million recorded in Q2 2025.
- CureVac's 5-year Enterprise Value high stood at -$6.1 million for Q1 2022, and its period low was -$1.6 billion during Q1 2021.
- Moreover, its 5-year median value for Enterprise Value was -$510.7 million (2025), whereas its average is -$538.2 million.
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 9961.48% in 2022, then tumbled by 861319.62% in 2023.
- Quarter analysis of 5 years shows CureVac's Enterprise Value stood at -$933.6 million in 2021, then skyrocketed by 45.33% to -$510.4 million in 2022, then rose by 14.6% to -$435.9 million in 2023, then decreased by 18.99% to -$518.7 million in 2024, then decreased by 9.29% to -$566.8 million in 2025.
- Its Enterprise Value stands at -$566.8 million for Q3 2025, versus -$448.0 million for Q2 2025 and -$510.7 million for Q1 2025.